ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学会発表・講演等
  2. 口頭発表

Ligand for translocator protein increases hippocampal expression of glial Abeta scavenger receptors and reduces Abeta in male mice & rats

https://repo.qst.go.jp/records/65089
https://repo.qst.go.jp/records/65089
a46c598d-77c8-49aa-910b-58f5f0af7e1a
Item type 会議発表用資料 / Presentation(1)
公開日 2013-07-31
タイトル
タイトル Ligand for translocator protein increases hippocampal expression of glial Abeta scavenger receptors and reduces Abeta in male mice & rats
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_c94f
資源タイプ conference object
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Barron, Anna

× Barron, Anna

WEKO 641417

Barron, Anna

Search repository
Tokunaga, Masaki

× Tokunaga, Masaki

WEKO 641418

Tokunaga, Masaki

Search repository
Ki, Hin

× Ki, Hin

WEKO 641419

Ki, Hin

Search repository
Suhara, Tetsuya

× Suhara, Tetsuya

WEKO 641420

Suhara, Tetsuya

Search repository
Higuchi, Makoto

× Higuchi, Makoto

WEKO 641421

Higuchi, Makoto

Search repository
Barron Anna

× Barron Anna

WEKO 641422

en Barron Anna

Search repository
徳永 正希

× 徳永 正希

WEKO 641423

en 徳永 正希

Search repository
季 斌

× 季 斌

WEKO 641424

en 季 斌

Search repository
須原 哲也

× 須原 哲也

WEKO 641425

en 須原 哲也

Search repository
樋口 真人

× 樋口 真人

WEKO 641426

en 樋口 真人

Search repository
抄録
内容記述タイプ Abstract
内容記述 Background
Translocator protein (TSPO) is a multi-functional mitochondrial transmembrane protein primarily localised in steroid-producing tissues, including the brain. TSPO ligands elicit pleiotropic neuroprotective and cognitive benefits, mechanistically linked to the regulation of steroid synthesis and gliosis. Our recent findings in 3xTgAD mice demonstrate that TSPO ligands not only reduce development of Abeta neuropathology in young mice, but also reverse pathology in aged mice, suggesting TSPO ligands may promote Abeta clearance. Since glia-mediated Abeta phagocytosis and degradation is an important mechanism of brain Abeta clearance, we investigated the effect of a TSPO ligand on markers of glial function and expression of glial Abeta-scavenging receptors.
Methods
Effects of the TSPO ligands, Ro5-4864 and PK-11195, on brain Abeta levels in mice were assessed. The dose dependent effects of the most effective ligand, Ro5-4864, were compared with the anti-amyloidogenic neuroactive steroid, testosterone, in rats. Abeta levels were assessed by ELISA and hippocampal mRNA expression of markers of glial function (glial fibrillary acidic protein; GFAP; major histopatability complex II; MHC II; interleukin-1beta; IL-1beta; tumor necrosis factor-alpha, TNF-alpha) and glial Abeta scavenger receptors (scavenger receptor-A1, SR-A1; scavenger receptor-B1, SR-B1) were assessed by PCR.
Results
Ro5-4864 reduced Abeta-40 more effectively than PK-11195, while combined Ro5-4864 + PK-11195 had an additive anti-amyloidogenic effect. In rats, Ro5-4864 dose-dependently reduced Abeta-40 levels and was equally effective as testosterone. In Ro5-4864 treated rats, reduced Abeta levels were associated with elevated expression of GFAP, MHC-II, and glial Abeta scavenger receptors; although levels of the pro-inflammatory cytokines, IL-1beta and TNFalpha, were unaltered. In contrast, testosterone had an anti-inflammatory effect, reducing levels of GFAP, MHC-II, IL-1beta and TNF-alpha, without altering expression of glial scavenger receptors.
Conclusions
The TSPO ligand Ro5-4864 may promote trophic glial activity, including increasing Abeta phagocytic capacity in the absence of detrimental proinflammatory cytokine production. Since glial TSPO is upregulated in the most severely affected regions of the Alzheimer`s brain, TSPO ligands may selectively target regions most affected by the disease. Many new generation, safe TSPO ligands have been developed for in vivo imaging in humans, however our findings suggest these ligands may also have a therapeutic potential for the treatment of Alzheimer`s.
会議概要(会議名, 開催地, 会期, 主催者等)
内容記述タイプ Other
内容記述 The Alzheimer's Association International Conference 2013
発表年月日
日付 2013-07-18
日付タイプ Issued
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 21:04:11.561056
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3